CI INVESTMENTS INC. - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.

Quarter-by-quarter ownership
CI INVESTMENTS INC. ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2016$6,985,000
+5.0%
65,700
+13.1%
0.08%
-7.1%
Q1 2016$6,651,000
-16.0%
58,100
+4.5%
0.08%
-15.8%
Q4 2015$7,921,000
+94.7%
55,600
+22.7%
0.10%
+90.6%
Q3 2015$4,069,000
-17.4%
45,300
+5.8%
0.05%
-1.9%
Q2 2015$4,929,000
+58.3%
42,800
+31.3%
0.05%
+63.6%
Q1 2015$3,114,00032,6000.03%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2016
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 287,277$35,760,00028.32%
WARBURG PINCUS LLC 6,674$830,780,00013.45%
Ariose Capital Management Ltd 238,841$27,689,0007.56%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 12,600$1,568,0004.48%
RUDMAN ERROL M 37,001$4,606,0003.72%
INDUS CAPITAL PARTNERS, LLC 245,237$30,527,0002.89%
Ativo Capital Management LLC 93,784$11,674,0002.70%
OBERWEIS ASSET MANAGEMENT INC/ 63,305$7,880,0002.27%
Point72 Hong Kong Ltd 31,500$3,921,0002.14%
Cormorant Asset Management, LP 112,867$14,050,0001.55%
View complete list of CHINA BIOLOGIC PRODS INC shareholders